ulcer disease and distal gastric cancer (38) . Two important virulence factors produced by H. pylori strains are a vacuolating cytotoxin (VacA) and products of a 40-kb genetic locus of ϳ31 genes termed the cag pathogenicity island (PAI) (8) . VacA is a secreted toxin that produced multiple functional and morphological changes within gastric epithelial cells (36) . The cag PAI encodes proteins that act to form a type IV secretion system that is responsible for translocation of the H. pylori CagA protein into gastric cells (2, 6, 12, 33, 51, 56) . The picB/cagE gene, which encodes a homolog of the Agrobacterium VirB4 ATPase, is also necessary for the translocation of the H. pylori CagA protein into the gastric cell (6, 14, 17, 33) . Also, products of the cag PAI act to induce synthesis and secretion of IL-8 (60), increase MAP kinase activity (20) , induce gastric epithelial cell proliferation and apoptosis (18, 39) , and induce transactivation of the epidermal growth factor receptor (EGFR) (21) and cyclooxygenase-2 mRNA expression (45) . Other mutagenesis studies involving the cag PAI have found that disruption of the cagA gene resulted in a reduction in gastric cell arachidonic acid release and prostaglandin E 2 synthesis (40), in a decreased stress kinase gene expression (30) , and in reduced expression of the protooncogenes c-fos and c-jun (26) . The presence of the cagA gene and its expressed product, the CagA protein, have also been reported as necessary for the induction of specific gastric cell morphological changes such as cell elongation, spreading, and scattering, which has been designated as the "hummingbird" phenotype (5, 16, (49) (50) (51) . Of interest is a recent study suggesting that just the presence of the CagA protein (an not necessarily phosphorylated CagA protein) can induce this hummingbird phenotype (27) . Other H. pylori-induced morphological changes, such as gastric cell stress fiber formation, were shown to be cagA and vacA independent (49) .
Despite the recent advances in H. pylori-host cell mutagenesis and transcriptional profiling (14) , little is known about certain aspects of H. pylori signaling in normal gastric cells such as the regulation of intracellular Ca 2ϩ concentrations ([Ca 2ϩ ] i ). In other model systems, bacterial adherence to the host cell has been shown to result in specific [Ca 2ϩ ] i changes (10) . For example, the adherence of certain Escherichia coli strains to intestinal epithelial cells results in increased [Ca 2ϩ ] i and inositol trisphosphate levels (11) . It has also been shown that Salmonella induces intracellular Ca 2ϩ changes that were linked to the activation of an NF-B-dependent inflammatory pathway (13) . In this regard, a study using the intracellular Ca 2ϩ chelator BAPTA along with calmodulin inhibitors found that H. pylori activation of NF-B and IL-8 signaling in MKN45 human gastric cancer cells was Ca 2ϩ -calmodulin dependent (32) . The reported H. pylori-induced hummingbird phenotype in gastric cells is similar to the morphological events seen with hepatocyte growth factor or scatter factor (HGF/SF) on MDCK cells or hepatocytes (44) . It has also been reported that HGF/SF can induce changes in [Ca 2ϩ ] i , which have been shown to be linked to changes in cell morphology and proliferation (1, 19, 31, 34) .
However, despite the extensive work on various aspects of H. pylori-induced signaling in gastric cancer cells, the specific mechanism(s) of intracellular Ca 2ϩ mobilization by H. pylori in normal human gastric mucous epithelial cells has not yet been thoroughly examined. Also, many H. pylori signaling studies have used either nongastric or gastric cancer cell lines as a model system, which always introduces a degree of uncertainty as to whether the events observed are applicable to normal gastric cells. As an alternative to nongastric gastric cancer cell lines, several in vitro model systems of normal human gastric mucous epithelial cells have been established (7, 48, 54, 61) . The use of nontransformed cell culture models provides a more accurate representation of the environment that H. pylori may encounter in the normal human gastric mucosa. The aim of the present study, therefore, was to examine the effects of H. pylori on intracellular Ca 2ϩ signaling in normal human gastric epithelial cells. We found for the first time that H. pylori produces specific transient [Ca 2ϩ ] i changes in normal human gastric mucous epithelial cells and that these H. pylori-induced [Ca 2ϩ ] i changes could also be replicated in a nontransformed gastric mucous epithelial cell line (HFE-145 cells). We also found that a G protein-dependent/PLC pathway primarily regulated H. pylori-induced intracellular Ca 2ϩ release, whereas H. pylori-induced Ca 2ϩ influx was primarily regulated by components of a G protein-, src kinase-, and PLA 2 -dependent pathway. Finally, we report that mutagenesis of picB/cagE and cagA genes (located within the cag PAI), but not the vacA gene, alters the capacity of H. pylori to produce a full [Ca 2ϩ ] i response.
MATERIALS AND METHODS
Chemicals and peptides. The Ca 2ϩ probes fura 2-AM and fluo 4-AM (special packaging) as well as BAPTA-AM were purchased from Molecular Probes (Eugene, OR) and stored at Ϫ20°C until needed. All Ca 2ϩ probes were freshly prepared as 5-mM stock solutions on the day of the experiment by dissolving preweighed aliquots in cultured-grade DMSO (Sigma, St. Louis, MO). The compounds methyl arachidonyl fluorophosphate (MAFP), thapsigargin, 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo [3,4-d] pyrinidine (PP2), pertussis toxin (PTX), U-73122, and U-73343 were purchased from Calbiochem (San Diego, CA). Type I collagenase, RIA grade BSA powder, Triton X-100, digitonin, and genistein were purchased from Sigma. Cell culture media were from GIBCO (San Diego, CA), and FBS was from Hyclone (Logan, UT).
Unless noted otherwise, all Falcon cell culture plasticware was purchased from Fisher Scientific (San Francisco, CA). Gastric epithelial cell culture. Human gastric mucous cells were isolated and cultured as previously described (48) . The Oregon Health Sciences University (OHSU) Human Studies Subcommittee approved all procedures and handling of human tissue. Briefly, H. pylori-free gastric tissues were obtained from patients undergoing surgical gastrectomy. The surgical specimens were washed twice in serum-free media and pinned down on polymerized Sylgard, and the epithelium was removed by scraping the surface with a glass slide. The scraped tissue pieces were minced by using razor blades then washed three times at 100 g for 3 min in serum-free media. The pellets were then transferred to siliconized 125-ml screw-cap Erlenmeyer flasks containing 20 ml of serum-free culture media with 20 mg/ml of type I collagenase and 0.1% bovine serum albumin. The flasks were then gassed with 95% O 2-5% CO2, put into a 37°C shaking water bath, and gyrated at 120 oscillations/min for 45 min. At the end of the incubation period, the collagenase-digested mixture was put into a 50-ml syringe with an attached 15-gauge luer-stub adapter, and the contents were pushed through a 200-m nylon mesh screen. The mesh-filtered suspension was washed twice in serum-free media and centrifuged at 100 g for 3 min, then the pellet was resuspended in 15 ml of serum-free culture media and a 200-l aliquot was taken for cell counts in a Coulter Counter. The 15-ml suspension was divided into three 5-ml aliquots in 16 ϫ 125-cm Falcon round-bottom tubes, then 5 ml of isosmotic Percoll was added to each tube. The tubes were centrifuged for 15 min at 100 g at 24°C, and the bottom pellet, containing the gastric mucous epithelial cells, was removed. The pellet was washed three times and centrifuged at 20 g for 3 min in serum-free cell culture media, then the cells were plated on 0.45-m Falcon porous filters (catalog no. 353180; 12 mm, 0.45-m pore size), 25 mm round glass coverslips, or 96-well plastic dishes.
The HFE-145 human gastric mucous epithelial cell line (provided by D. Smoot) were plated and grown under the same experimental conditions as the above human primary gastric mucous epithelial cells. The HFE-145 cells were originally developed from normal human gastric epithelial cells by the transfection of normal cells with SV40 Large T-antigen and human telomerase vectors (53) . The cells have a doubling time of ϳ24 h and are strongly positive for cytokeratin-10,11,18 and weakly positive for cytokeratin -13,16,20 , which is almost identical to cytokeratin staining of the parental cell line. These cells also stain positive for neutral mucin using periodic acid-Schiff and negative for alcian blue (acidic mucin), which is consistent with normal gastric epithelial cells. Growth of these cells was inhibited when cells were placed in soft agar, suggesting that these cells are not tumorigenic. The cells constitutively express mRNA from Muc-5ac, Muc-5b, and Muc-6 genes, which is consistent with normal gastric epithelial cells. Electron microscopy shows that these cells form tight junctions when grown as monolayers on plastic tissue culture dishes and on glass slides (53 (39, 52, 59) . The bacteria were grown on blood agar plates (trypticase soy agar with 5% sheep blood; PML Microbiologicals, Tualatin, OR) under microaerobic conditions using a CampyPak jar (Fisher Scientific) at 36°C. Unless noted otherwise, all bacteria were harvested at 24 h by using a sterile cotton swab and 3 ml of PBS (pH 7.1). The bacterial suspensions were put into 12-ml Falcon round-bottom tubes, and the H. pylori was resuspended by gentle inversion. A 1-ml aliquot of the suspension was put into a cuvette, and the H. pylori concentration was determined by using optical density 600 nm (OD 600) where an OD of 1 ϭ 1.2 ϫ 10 9 colony-forming units (CFU)/ml. All final bacterial suspensions (1 ϫ 10 5 -1 ϫ 10 9 CFU/ml) were adjusted with the appropriate mammalian Ringer solution. The mammalian Ringer solution consisted of (in mM): 137 NaCl, 4 KCl, 25 NaHCO 3, 2 KH2PO4, 15 HEPES, 1 MgSO4, 2 CaCl 2, and 25 glucose, pH 7.4. Periodically, the bacteria were plated in serial dilutions on agar plates and H. pylori concentrations were checked by counting the bacterial colonies after 3 days of incubation.
H. pylori sonicates were made by growing the bacteria on agar plates for 24 h and then harvesting the bacteria in PBS as indicated above. The bacteria were washed twice in PBS by centrifugation at 10,000 g for 15 min, and then the pellet was resuspended in mammalian Ringer (pH 7.4). The bacterial suspensions were disrupted by sonication (10 30-s pulses), the sonicates were filtered through a 0.2-m filter, and the protein content was determined by using a Bio-Rad protein assay. Aliquots were frozen and stored at Ϫ80°C until needed. For control studies, both live bacteria and bacterial sonicates were heated to 70°C for 30 min to generate heatinactivated bacteria and sonicates.
H. pylori and gastric cell [Ca 2ϩ ]i using fura 2. Primary cultures of gastric mucous epithelial cells, the HFE-145 cell line, and AGS gastric cancer cells were grown on either permeable Falcon filters or 25-mm round glass coverslips. After 24 h in serum-free media, the cells were loaded with fura 2-AM according to modifications of previously described techniques (47) . Briefly, the cells were loaded with 2.5 M fura 2-AM in fresh serum-free media for 45 min at 37°C. After fura 2-AM loading, the cells were washed twice with fresh serum-free media, then twice with mammalian Ringer. When extracellular Ca 2ϩ -free Ringer solutions were used, the CaCl2 was replaced with NaCl and the solution was characterized as nominally Ca 2ϩ -free Ringer. In preliminary experiments, we found that the use of our nominally Ca 2ϩ -free Ringer solution did not affect H. pylori adherence. However, the addition of 1 mM EDTA and 1 mM EGTA to the nominally Ca 2ϩ -free Ringer solution decreased H. pylori adherence and disrupted monolayer integrity over the experimental time period and therefore could not be used (data not shown). Solutions were oxygenated with 5% CO2-95% O2, kept warm at 37°C in a heated water bath, and perfused into the chamber by using a variable Millipore pump.
After fura 2 loading, the gastric cultures were transferred to a horizontal open perfusion chamber that had been modified to hold either a permeable Falcon filter or a glass coverslip (46) . The chamber was then placed on the stage of a Nikon Diaphot TMD inverted microscope equipped with a fluorescence objective (Nikon Fluor-phase-3DM, numerical aperature 60/0.7, 160-mm working distance). [Ca 2ϩ ]i measurements were made at 340/380 nm excitation and 510 nm emission wavelengths from an SLM-Aminco spectrophotometer (Rochester, NY). The effects of nonspecific H. pylori fluorescence scatter and cell autofluorescence were determined by placing an unloaded gastric cell monolayer with varying doses of H. pylori (1 ϫ 10 5 -1 ϫ 10 9 CFU/ml) on the microscope stage, then emission ratios were recorded and subtracted from the final fura 2 tracings. In preliminary experiments, we found light scattering by the bacteria and cellular autofluorescence did not exceed 5% of the total fura 2 fluorescence.
In some experiments, the rates of H. pylori-induced intracellular Ca 2ϩ release and influx were estimated by using the "Ca 2ϩ add-back technique" (43 ]i change is measured as Ca 2ϩ influx. The final calibration of the fura 2 signal was done at the end of each experiment by adding 5 M ionomycin for 10 min to saturate fura 2 with Ca 2ϩ to obtain maximal fluorescence (Fmax), then 10 mM EGTA and 10 mM EDTA plus 60 mM Tris ⅐ HCl, pH 10.5, was added to chelate the Ca 2ϩ from fura 2 to determine the minimal fluorescence (F min). Additional points on the calibration curve were determined by using a series of defined Ca 2ϩ -calibration solutions (Kit #1, C-3008; Molecular Probes), and [Ca 2ϩ ]i was calculated (58) . The fluorescence tracing analysis and data smoothing were done with software provided by the manufacturer (SLM-Aminco).
H. pylori and gastric cell [Ca 2ϩ ]i using a fluo 4 96-well assay.
In some experiments we wanted a quicker throughput assay to measure the relative change in Statistics. All data are expressed as means Ϯ SE. The differences between means were considered significant when the P value calculated from Students' t-test for paired cultures was Ͻ0.05. Multiple cell culture comparisons were analyzed by using ANOVA and Duncan's multiple-range tests. Unless stated otherwise, n represents the total number of different "individual" cell preparations isolated from different surgical specimens. All statistical calculations were made using SigmaStat statistical software (SPSS, San Rafael, CA).
RESULTS

H. pylori mobilizes intracellular Ca
2ϩ in normal gastric mucous epithelial cells. For the first series of experiments, we used a modified horizontal chamber on an inverted microscope connected to a spectrophotom-eter. This particular setup has the advantage that smaller volumes can be used, allowing a quicker rate of H. pylori settling and adherence to the gastric cells. Before the addition of H. pylori, a baseline fluorescence measurement was taken of the fura 2-loaded gastric mucous cell cultures, then varying doses of H. pylori (1 ϫ 10 5 -1 ϫ 10 9 CFU/ml) were added and [Ca 2ϩ ] i was measured. As shown in the composite tracings in Fig.  1 , we found that wild-type H. pylori (strain 60190) induced a dose-dependent change in [Ca 2ϩ ] i in primary cultures of human gastric mucous epithelial cells. Over the time course of 60 min, the wild-type strain produced a characteristic biphasic [Ca 2ϩ ] i increase (transient "peak") that was followed by a decline and then a return to above [Ca 2ϩ ] i baseline values ("plateau" phase) (Fig. 1) . At the highest H. pylori concentration used (1 ϫ 10 9 CFU/ml), there was a change in [Ca 2ϩ ] i from a basal level of 104 Ϯ 2 nM to a peak of 184 Ϯ 4 nM, followed by a decline and then a rise again to a plateau level of 145 Ϯ 4 nM (n ϭ 14; Table 1 ).
To independently validate the previous results, we tested the effects of H. pylori on [Ca 2ϩ ] i in the nontumorigenic HFE-145 human gastric mucous epithelial cell line. The HFE-145 cell line has morphological and phenotypic properties similar to those seen in primary gastric mucous epithelial cells (53) . Compared with the primary gastric mucous epithelial cell cultures, we found that H. pylori produced similar [Ca 2ϩ ] i changes in the HFE-145 cell line (Fig. 1B) . That is, H. pylori dose-dependently produced the characteristic biphasic peak and plateau changes in [Ca 2ϩ ] i ( Fig. 1B ; Table 1 ). For example, H. pylori (1 ϫ 10 9 CFU/ml) produced a change in baseline [Ca 2ϩ ] i from 106 Ϯ 2 nM to a peak of 177 Ϯ 4 nM, which was followed by a decline and then an increase to plateau levels of 140 Ϯ 4 nM (n ϭ 14; Table 1 ). Although some quantitative differences in H. pylori-induced intracellular Ca 2ϩ signaling existed between the primary human gastric mucous epithelial cell cultures and the HFE-145 cell line, overall the qualitative patterns of H. pylori-induced [Ca 2ϩ ] i changes were similar in both cell types. It should be noted that after several passages (Ͼ25) of the HFE-145 cell line, we began to lose the characteristic H. pyloriinduced intracellular Ca 2ϩ response that was observed in early cultures (data not shown).
In addition to live bacteria, we also tested the capacity of H. pylori sonicates (0-5 g/ml) to induce changes in [Ca 2ϩ ] i in normal gastric mucous epithelial cells. However, we found that the H. pylori sonicates, even at the highest concentration used (5 g/ml), produced only a small, slow, steady change in [Ca 2ϩ ] i from a baseline level of 103 Ϯ 3 nM to 119 Ϯ 4 nM over a 60-min time course (n ϭ 9). Because the bacterial sonicates did not reproduce the [Ca 2ϩ ] i changes observed with live intact H. pylori, they were not used for the remainder of our experiments. Compared with the untreated control cultures, we also found that heatkilled H. pylori produced no significant change (P Ͼ 0.05) in [Ca 2ϩ ] i over the 60-min time period (control ϭ 106 Ϯ 3 nM; heat-killed bacteria ϭ 108 Ϯ 4 nM; n ϭ 9; Fig. 1 (Fig. 3A) . Because the cagA Ϫ and picB Ϫ /cagE Ϫ H. pylori strains were previously found to produce no [Ca 2ϩ ] i plateau change (see Fig. 2 ), the thapsigargin pretreatment of the gastric cells was without effect on this portion of the [Ca 2ϩ ] i response (Fig. 3B) (Fig. 5, C and D) . As a control, cultures were pretreated with the structurally related but ineffective PLC drug U-73343, and it (Fig. 6, A and B) . Only at higher concentrations of PP2 (15 M) did we observe a reduction in both the H. pylori wild-type strain and vacA Ϫ mutant [Ca 2ϩ ] i peak and plateau changes to baseline levels (Fig. 6, A and B) . We also found that only at the highest PP2 concentration used (15 M) was the cagA Ϫ and picB Ϫ /cagE Ϫ [Ca 2ϩ ] i peak change reduced to baseline levels (Fig. 6, C and D Fig. 2 ), the PP2 was without effect on this portion of the [Ca 2ϩ ] i response (Fig. 6, C and D) ] i peak and plateau changes to baseline [Ca 2ϩ ] i levels (Fig. 7, A and B) . ] i peak change to near baseline levels (Fig. 7, C and D) . Because the cagA Ϫ Fig. 4 Fig. 8 A and  B) . Also, MAFP had no significant effect (P Ͼ 0.05) on the cagA Ϫ or picB
] i peak change (Fig. 8, C and D ] i response (Fig. 8, C and D) . Overall, these results suggest that the H. pylori-induced plateau phase (Ca 2ϩ influx) is under the regulation of a G protein/cPLA 2 -dependent pathway.
DISCUSSION
Pathogenic bacteria have developed a variety of mechanisms to survive and interact with their respective host cells, where they exploit their respective host cell signaling pathways (11) . H. pylori has also been shown to activate or use several different signaling pathways within the host gastric cell that eventually lead to the development of ulcers or gastric cancer (38, 57) . However, the effect of H. pylori on intracellular Ca 2ϩ signaling in normal human gastric epithelial cells has not been investigated. The present study is the first to describe the effects of H. pylori on the regulation of [Ca 2ϩ ] i changes in this cell type. We found that wild-type H. pylori produced a dose-dependent biphasic [Ca 2ϩ ] i change within primary human gastric mucous epithelial cells and in a nontransformed gastric mucous epithelial cell line (HFE-145 cells) ] i response was also found to consist of two phases, the first being the release of Ca 2ϩ from intracellular Ca 2ϩ stores (peak phase) followed by the activation of a Ca 2ϩ -influx mechanism (plateau phase).
In the present study, we also examined a role for the H. pylori vacA, cagA, and picB/cagE genes on intracellular Ca 2ϩ signaling. The H. pylori VacA toxin has been shown to produce several membrane permeability events in gastric cells, and it is also an important virulence factor in the pathogenesis of peptic ulcer disease (36 cPLA 2 activity will increase arachidonic acid, which can modulate Ca 2ϩ influx (23) . It is possible that the first H. pylori-induced phase of intracellular Ca 2ϩ mobilization will secondarily activate cPLA 2 , which in turn could generate arachidonic acid and modulate Ca 2ϩ influx (Fig. 9) . H. pylori, Ca 2ϩ signaling, and host cell pathogenesis. It is now known that H. pylori can initiate multiple signaling pathways within the host gastric cell by using a variety of effector stimuli, ranging from small extracellular molecules, such as urease-generated ammonia, to the VacA toxin or the use of specialized injected molecules such as the CagA protein (57) . As a focus for our own study, we chose to look at what role the VacA toxin, the CagA protein, and a functional type IV injection system may have on intracellular Ca 2ϩ signaling in normal human gastric mucous epithelial cells. We also chose to use a buffered urea-free Ringer solution (pH 7.4) to help minimize the potential effects that H. pylori-generated urease activity or ammonia might have on the overall H. pylori-induced [Ca 2ϩ ] i change (4) . However, we cannot rule out in our study the contribution of other H. pylori-secreted/shed factors that may contribute to the overall [Ca 2ϩ ] i response (29) . In addition, some of the H. pylori extracellular shed/secreted proteins, such as HP0305, have been reported to have sequence homology to regulators of G protein signaling, which makes it possible that these proteins could modulate or contribute to the overall H. pylori host cell [Ca 2ϩ ] i response (22) . However, because H. pylori was able to increase [Ca 2ϩ ] i within minutes after the addition of the bacteria, we believe that soon after bacteria adherence, certain signaling intermediates are immediately activated, such as G proteins and PLC, which were both found to be important in the H. pylori-induced [Ca 2ϩ ] i peak change (Fig. 9) . In other cell types, it is well established that agonists or pathogens can quickly increase PLC activity and the formation of inositol trisphosphate, which releases Ca 2ϩ from intracellular Ca 2ϩ stores (3). Our time-course and inhibitor studies suggest that H. pylori is likely to involve a similar PLC pathway that produced the characteristic rise and fall of [ (32) . It has also been reported that BAPTA was able to block H. pylori-induced arachidonic acid release that is involved in the production of prostaglandin E 2 (40) . Of interest, however, was the fact that the expression of the CagA protein was not important for the above-mentioned Ca 2ϩ -dependent H. pylori-induced IL-8 release (32), whereas the CagA protein was necessary for Ca 2ϩ -dependent H. pyloriinduced arachidonic acid synthesis (40 ] i signal, i.e., the peak and plateau phases, may be utilized differently depending on the nature of the Ca 2ϩ -dependent signaling molecule within the host gastric cell. It also appears that differential signaling by H. pylori may hold true for other gastric host cell responses. That is, H. pylori-induced MAP kinase activity has also been reported to be induced in a "biphasic" manner over several hours (27) . In addition, recent microarray transcriptional studies of H. pylori-treated AGS gastric cancer cells found that many H. pylori-induced signaling genes are transiently expressed within 1 h (14) . It is also highly likely that there are other genes inside or outside the H. pylori cag PAI, as well certain structural components from H. pylori itself, that could participate in the H. pylori-induced [Ca 2ϩ ] i response. For example, it has been suggested that the direct binding of the defective picB/cagE type IV injection apparatus to the plasma cell membrane itself is enough to activate other receptors, as well as translocate other unknown molecules through the type IV injection apparatus that can participate in host cell responses (51) .
In summary, we found that H. pylori produces specific transient [Ca 2ϩ ] i changes in normal human gastric mucous epithelial cells and that these H. pyloriinduced [Ca 2ϩ ] i changes could also be replicated in a nontransformed gastric mucous epithelial cell line (HFE-145 cells) . A G protein/PLC-dependent pathway primarily regulated the H. pylori-induced intracellular Ca 2ϩ release, whereas H. pylori-induced Ca 2ϩ influx was under the control of a G protein-, src kinase-, and PLA 2 -dependent pathway (Fig. 9) . Finally, we report that mutagenesis of picB/cagE and cagA genes (located within the cag PAI), but not the vacA gene, alters the capacity of H. pylori to produce a full [Ca 2ϩ ] i response.
For future studies, it will be important to look at other genes inside and outside the cag PAI to determine their effects on H. pylori-induced [Ca 2ϩ ] i changes.
